GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

FOR well over a million Brits, fat jabs have been a game-changer – ending ‘food noise’, dulling hunger pangs and helping the ...

Please provide your email address to receive an email when new articles are posted on . Remote intervention induced significant weight loss for women with breast cancer and obesity. Weight loss was ...

The highest prevalent prescription rates were observed in thyroid (10.1%), breast (7.2%), and endometrial (7.1%) cancers, ...

Weight loss jabs could “protect” people from contracting cancer, scientists have discovered. Findings presented at this year’s European Congress on Obesity in Malaga, Spain, say older weight-loss ...

Obesity has many adverse effects in patients with breast and other cancers. In this analysis, breast cancer patients randomized to a behavioral weight-loss intervention lost an average of 4.7% of ...